Laleman W - Search Results

1

Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis.

Trebicka J, Hennenberg M, Schulze Pröbsting A, Laleman W, Klein S, Granzow M, Nevens F, Zaagsma J, Heller J, Sauerbruch T. Trebicka J, et al. Among authors: laleman w. Hepatology. 2009 Dec;50(6):1924-35. doi: 10.1002/hep.23222. Hepatology. 2009. PMID: 19842096

2

A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis.

Laleman W, Omasta A, Van de Casteele M, Zeegers M, Vander Elst I, Van Landeghem L, Severi T, van Pelt J, Roskams T, Fevery J, Nevens F. Laleman W, et al. Hepatology. 2005 Dec;42(6):1382-90. doi: 10.1002/hep.20968. Hepatology. 2005. PMID: 16317694

3

Portal hypertension: from pathophysiology to clinical practice.

Laleman W, Landeghem L, Wilmer A, Fevery J, Nevens F. Laleman W, et al. Liver Int. 2005 Dec;25(6):1079-90. doi: 10.1111/j.1478-3231.2005.01163.x. Liver Int. 2005. PMID: 16343056 Review.

4

A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.

Laleman W, Vander Elst I, Zeegers M, Servaes R, Libbrecht L, Roskams T, Fevery J, Nevens F. Laleman W, et al. Eur J Clin Invest. 2006 Apr;36(4):242-9. doi: 10.1111/j.1365-2362.2006.01620.x. Eur J Clin Invest. 2006. PMID: 16620286

5

Both Ca2+ -dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine.

Laleman W, Van Landeghem L, Severi T, Vander Elst I, Zeegers M, Bisschops R, Van Pelt J, Roskams T, Cassiman D, Fevery J, Nevens F. Laleman W, et al. Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G556-64. doi: 10.1152/ajpgi.00196.2006. Epub 2006 Sep 28. Am J Physiol Gastrointest Liver Physiol. 2007. PMID: 17008556 Free article.

6

Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.

Laleman W, Nevens F. Laleman W, et al. Minerva Med. 2006 Aug;97(4):325-45. Minerva Med. 2006. PMID: 17008837 Review.

7

Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.

Laleman W, Van Landeghem L, Van der Elst I, Zeegers M, Fevery J, Nevens F. Laleman W, et al. Gastroenterology. 2007 Feb;132(2):709-19. doi: 10.1053/j.gastro.2006.12.041. Epub 2006 Dec 20. Gastroenterology. 2007. PMID: 17258737

8

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase.

Trebicka J, Hennenberg M, Laleman W, Shelest N, Biecker E, Schepke M, Nevens F, Sauerbruch T, Heller J. Trebicka J, et al. Among authors: laleman w. Hepatology. 2007 Jul;46(1):242-53. doi: 10.1002/hep.21673. Hepatology. 2007. PMID: 17596891

9

Carbon monoxide produced by intrasinusoidally located haem-oxygenase-1 regulates the vascular tone in cirrhotic rat liver.

Van Landeghem L, Laleman W, Vander Elst I, Zeegers M, van Pelt J, Cassiman D, Nevens F. Van Landeghem L, et al. Among authors: laleman w. Liver Int. 2009 May;29(5):650-60. doi: 10.1111/j.1478-3231.2008.01857.x. Epub 2008 Sep 15. Liver Int. 2009. PMID: 18795901

10

Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.

Lowette KF, Desmet K, Witters P, Laleman W, Verslype C, Nevens F, Fevery J, Cassiman DM. Lowette KF, et al. Among authors: laleman w. Eur J Gastroenterol Hepatol. 2010 May;22(5):564-71. doi: 10.1097/MEG.0b013e3283353df8. Eur J Gastroenterol Hepatol. 2010. PMID: 20042865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters